Evidence map›Paper›PMID 40449353›Full record

ArticleThe Science of the total environment2025

Associations of volatile organic compounds with accelerated epigenetic aging in the lungs of smokers and electronic cigarette users.

Ajmal Khan, Carson Richardson, Joseph P McElroy, Amarnath Singh, Daniel Y Weng, Sahar Kamel, Sarah A Reisinger, Mark D Wewers, Peter G Shields, Min-Ae Song

Abstract read
In one paragraph

Article in The Science of the total environment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ajmal KhanDivision of Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, OH, USA.
Carson RichardsonCenter for Biostatistics, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Joseph P McElroyCenter for Biostatistics, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Amarnath SinghComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, OH, USA.
Daniel Y WengComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, OH, USA.
Sahar KamelComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, OH, USA.
Sarah A ReisingerComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, OH, USA.
Mark D WewersPulmonary and Critical Care Medicine, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Peter G ShieldsComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, OH, USA; Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. Electronic address: Peter.Shields@osumc.edu.
Min-Ae SongDivision of Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, OH, USA; Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. Electronic address: Song.991@osu.edu.

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve HealthUM1TR004548 · NCATS · OHIO STATE UNIVERSITY · PI CYNTHIA A GERHARDT, JULIE A. JOHNSON · 2023 to 2026
$22.0M
Project 4: Comprehension of Health Risks in More and Less Arousing Affe p240-275P50CA180908 · NCI · OHIO STATE UNIVERSITY · PI SHIELDS, PETER G., WEWERS, MARY ELLEN · 2013 to 2017
$18.9M
NCATS NIH HHS UL1 TR001070NCATS NIH HHS UM1 TR004548NCI NIH HHS P30 CA016058NCI NIH HHS P50 CA180908
6 · The paper itself

Abstract

backgroundCigarette smoke and electronic cigarettes (EC) contain volatile organic compounds (VOCs) that can irritate the respiratory tract and affect pulmonary health. No studies have reported relationships between VOCs from smokers and EC users and pulmonary cellular behavior, such as lung biological aging.

methodsUsing urinary total nicotine equivalent (TNE) and propylene glycol, the primarily E-liquid constituent, the tobacco use status of smokers (SM, n = 13), EC users (n = 12), and never-smokers (NS, n = 31) was confirmed. In the lungs of SM and EC, we assessed methylation age (mAge) estimates and cellular senescence-related gene expression. Ten urinary metabolites of VOCs with and without adjusting for nicotine intake, TNE, were associated with mAge estimates and gene expression.

resultsCompared to EC users, SM had a significantly higher level of TNE-adjusted metabolites of acrylonitrile and 1,3-butadiene, while showing a lower level of a metabolite of benzene. TNE-adjusted metabolites of 1,3 butadiene, ethylene oxide, and acrylonitrile were overall positively associated with Pheno-mAge (an epigenetic clock for lifespan/mortality), with different patterns of the associations by smoking group. IFNG and STAT1 showed an overall positive association with TNE-adjusted metabolites of propylene oxide and acrylamide, with a stronger association in SM compared to EC. Without controlling for TNE, a benzene metabolite was the only significant associated with POU5F1.

conclusionsThis is the first study reporting associations between smoking/EC-related VOCs and lung biological aging with strong associations in SM, supporting the need for further research on the roles of VOCs-related epigenetic aging and cell senescence genes in pulmonary diseases.

Indexed as

AgingElectronic Nicotine Delivery SystemsEpigenesis, GeneticLungSmokingVolatile Organic CompoundsAdultFemaleHumansMaleMiddle AgedSmokersVolatile Organic CompoundsElectronic cigarettesEpigenetic agingLungsSmokingVolatile organic compounds

Identifiers

PMID40449353
PMCPMC13318086

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.